nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentamidine—CYP4A11—Cisplatin—esophageal cancer	0.516	1	CbGbCtD
Pentamidine—Rales—Capecitabine—esophageal cancer	0.00229	0.0111	CcSEcCtD
Pentamidine—Inappropriate antidiuretic hormone secretion—Cisplatin—esophageal cancer	0.00219	0.0106	CcSEcCtD
Pentamidine—Serum creatinine increased—Cisplatin—esophageal cancer	0.00207	0.01	CcSEcCtD
Pentamidine—Chest tightness—Capecitabine—esophageal cancer	0.002	0.00968	CcSEcCtD
Pentamidine—Pneumothorax—Capecitabine—esophageal cancer	0.00189	0.00912	CcSEcCtD
Pentamidine—Night sweats—Capecitabine—esophageal cancer	0.00174	0.00841	CcSEcCtD
Pentamidine—Rales—Methotrexate—esophageal cancer	0.0017	0.00823	CcSEcCtD
Pentamidine—Necrosis—Cisplatin—esophageal cancer	0.00162	0.00784	CcSEcCtD
Pentamidine—Gastric ulcer—Capecitabine—esophageal cancer	0.00162	0.00781	CcSEcCtD
Pentamidine—Abscess—Cisplatin—esophageal cancer	0.00161	0.00778	CcSEcCtD
Pentamidine—Ageusia—Cisplatin—esophageal cancer	0.00157	0.0076	CcSEcCtD
Pentamidine—Infection—Carboplatin—esophageal cancer	0.00154	0.00744	CcSEcCtD
Pentamidine—Serum creatinine increased—Capecitabine—esophageal cancer	0.00153	0.00738	CcSEcCtD
Pentamidine—Raised liver function tests—Methotrexate—esophageal cancer	0.00151	0.00732	CcSEcCtD
Pentamidine—Hypomagnesaemia—Capecitabine—esophageal cancer	0.00148	0.00714	CcSEcCtD
Pentamidine—Oral candidiasis—Capecitabine—esophageal cancer	0.00148	0.00714	CcSEcCtD
Pentamidine—Extravasation—Cisplatin—esophageal cancer	0.00146	0.00705	CcSEcCtD
Pentamidine—Interstitial pneumonia—Methotrexate—esophageal cancer	0.00145	0.00699	CcSEcCtD
Pentamidine—Neuralgia—Capecitabine—esophageal cancer	0.00135	0.00653	CcSEcCtD
Pentamidine—Torsade de pointes—Capecitabine—esophageal cancer	0.00134	0.00647	CcSEcCtD
Pentamidine—Hepatomegaly—Capecitabine—esophageal cancer	0.00133	0.00641	CcSEcCtD
Pentamidine—Pain—Carboplatin—esophageal cancer	0.00132	0.0064	CcSEcCtD
Pentamidine—Azotaemia—Methotrexate—esophageal cancer	0.00131	0.00634	CcSEcCtD
Pentamidine—Laryngitis—Capecitabine—esophageal cancer	0.0013	0.00629	CcSEcCtD
Pentamidine—Haemoptysis—Capecitabine—esophageal cancer	0.00127	0.00613	CcSEcCtD
Pentamidine—Hyperkalaemia—Cisplatin—esophageal cancer	0.00125	0.00605	CcSEcCtD
Pentamidine—Herpes zoster—Capecitabine—esophageal cancer	0.00125	0.00603	CcSEcCtD
Pentamidine—Wheezing—Cisplatin—esophageal cancer	0.00124	0.00598	CcSEcCtD
Pentamidine—Body temperature increased—Carboplatin—esophageal cancer	0.00122	0.00592	CcSEcCtD
Pentamidine—Skin exfoliation—Cisplatin—esophageal cancer	0.00122	0.00588	CcSEcCtD
Pentamidine—Neuropathy—Cisplatin—esophageal cancer	0.0012	0.00578	CcSEcCtD
Pentamidine—Ageusia—Capecitabine—esophageal cancer	0.00116	0.0056	CcSEcCtD
Pentamidine—Phlebitis—Cisplatin—esophageal cancer	0.00107	0.00519	CcSEcCtD
Pentamidine—Chest discomfort—Capecitabine—esophageal cancer	0.00106	0.00513	CcSEcCtD
Pentamidine—Hypocalcaemia—Capecitabine—esophageal cancer	0.00103	0.00496	CcSEcCtD
Pentamidine—Nasal congestion—Cisplatin—esophageal cancer	0.00101	0.0049	CcSEcCtD
Pentamidine—Renal failure acute—Cisplatin—esophageal cancer	0.001	0.00484	CcSEcCtD
Pentamidine—Cyanosis—Methotrexate—esophageal cancer	0.000987	0.00477	CcSEcCtD
Pentamidine—Interstitial lung disease—Methotrexate—esophageal cancer	0.000987	0.00477	CcSEcCtD
Pentamidine—Lung disorder—Methotrexate—esophageal cancer	0.000987	0.00477	CcSEcCtD
Pentamidine—Amnesia—Cisplatin—esophageal cancer	0.000984	0.00476	CcSEcCtD
Pentamidine—Gait disturbance—Capecitabine—esophageal cancer	0.000962	0.00465	CcSEcCtD
Pentamidine—Cerebrovascular accident—Cisplatin—esophageal cancer	0.000943	0.00456	CcSEcCtD
Pentamidine—Herpes zoster—Methotrexate—esophageal cancer	0.000928	0.00449	CcSEcCtD
Pentamidine—Melaena—Capecitabine—esophageal cancer	0.000917	0.00443	CcSEcCtD
Pentamidine—Colitis—Capecitabine—esophageal cancer	0.000901	0.00436	CcSEcCtD
Pentamidine—Candida infection—Capecitabine—esophageal cancer	0.000896	0.00433	CcSEcCtD
Pentamidine—Skin exfoliation—Capecitabine—esophageal cancer	0.000896	0.00433	CcSEcCtD
Pentamidine—Face oedema—Cisplatin—esophageal cancer	0.000892	0.00431	CcSEcCtD
Pentamidine—Gingivitis—Methotrexate—esophageal cancer	0.00089	0.0043	CcSEcCtD
Pentamidine—Necrosis—Methotrexate—esophageal cancer	0.00089	0.0043	CcSEcCtD
Pentamidine—Abscess—Methotrexate—esophageal cancer	0.000883	0.00427	CcSEcCtD
Pentamidine—Neuropathy—Capecitabine—esophageal cancer	0.000881	0.00426	CcSEcCtD
Pentamidine—Blood creatinine increased—Cisplatin—esophageal cancer	0.000866	0.00419	CcSEcCtD
Pentamidine—Mouth ulceration—Capecitabine—esophageal cancer	0.000849	0.0041	CcSEcCtD
Pentamidine—Sepsis—Capecitabine—esophageal cancer	0.000815	0.00394	CcSEcCtD
Pentamidine—Extravasation—Methotrexate—esophageal cancer	0.000801	0.00387	CcSEcCtD
Pentamidine—Phlebitis—Capecitabine—esophageal cancer	0.000791	0.00382	CcSEcCtD
Pentamidine—Diabetes mellitus—Capecitabine—esophageal cancer	0.000783	0.00379	CcSEcCtD
Pentamidine—Pancreatitis—Cisplatin—esophageal cancer	0.000783	0.00379	CcSEcCtD
Pentamidine—Hepatic function abnormal—Capecitabine—esophageal cancer	0.00078	0.00377	CcSEcCtD
Pentamidine—Pancytopenia—Cisplatin—esophageal cancer	0.000759	0.00367	CcSEcCtD
Pentamidine—Eye pain—Capecitabine—esophageal cancer	0.000755	0.00365	CcSEcCtD
Pentamidine—Renal failure acute—Capecitabine—esophageal cancer	0.000738	0.00357	CcSEcCtD
Pentamidine—Amnesia—Capecitabine—esophageal cancer	0.000725	0.00351	CcSEcCtD
Pentamidine—Renal impairment—Capecitabine—esophageal cancer	0.000716	0.00346	CcSEcCtD
Pentamidine—Vasculitis—Methotrexate—esophageal cancer	0.000716	0.00346	CcSEcCtD
Pentamidine—Renal failure—Cisplatin—esophageal cancer	0.0007	0.00338	CcSEcCtD
Pentamidine—Neuropathy peripheral—Cisplatin—esophageal cancer	0.000698	0.00337	CcSEcCtD
Pentamidine—Cerebrovascular accident—Capecitabine—esophageal cancer	0.000695	0.00336	CcSEcCtD
Pentamidine—Lethargy—Capecitabine—esophageal cancer	0.000695	0.00336	CcSEcCtD
Pentamidine—Stomatitis—Cisplatin—esophageal cancer	0.000694	0.00336	CcSEcCtD
Pentamidine—Conjunctivitis—Cisplatin—esophageal cancer	0.000692	0.00335	CcSEcCtD
Pentamidine—Melaena—Methotrexate—esophageal cancer	0.000683	0.0033	CcSEcCtD
Pentamidine—Skin exfoliation—Methotrexate—esophageal cancer	0.000667	0.00322	CcSEcCtD
Pentamidine—Face oedema—Capecitabine—esophageal cancer	0.000658	0.00318	CcSEcCtD
Pentamidine—Bradycardia—Cisplatin—esophageal cancer	0.000651	0.00315	CcSEcCtD
Pentamidine—Mood swings—Capecitabine—esophageal cancer	0.000645	0.00312	CcSEcCtD
Pentamidine—Blood creatinine increased—Capecitabine—esophageal cancer	0.000638	0.00309	CcSEcCtD
Pentamidine—Mouth ulceration—Methotrexate—esophageal cancer	0.000632	0.00305	CcSEcCtD
Pentamidine—Liver function test abnormal—Capecitabine—esophageal cancer	0.000629	0.00304	CcSEcCtD
Pentamidine—Dry skin—Capecitabine—esophageal cancer	0.000625	0.00302	CcSEcCtD
Pentamidine—Sepsis—Methotrexate—esophageal cancer	0.000606	0.00293	CcSEcCtD
Pentamidine—Gastritis—Capecitabine—esophageal cancer	0.000603	0.00291	CcSEcCtD
Pentamidine—Flushing—Cisplatin—esophageal cancer	0.000593	0.00287	CcSEcCtD
Pentamidine—Asthma—Capecitabine—esophageal cancer	0.000589	0.00285	CcSEcCtD
Pentamidine—Influenza—Capecitabine—esophageal cancer	0.000589	0.00285	CcSEcCtD
Pentamidine—Diabetes mellitus—Methotrexate—esophageal cancer	0.000583	0.00282	CcSEcCtD
Pentamidine—Bronchospasm—Capecitabine—esophageal cancer	0.000579	0.0028	CcSEcCtD
Pentamidine—Arrhythmia—Cisplatin—esophageal cancer	0.000571	0.00276	CcSEcCtD
Pentamidine—Bronchitis—Capecitabine—esophageal cancer	0.000566	0.00274	CcSEcCtD
Pentamidine—Pancytopenia—Capecitabine—esophageal cancer	0.000559	0.0027	CcSEcCtD
Pentamidine—Erythema—Cisplatin—esophageal cancer	0.000557	0.00269	CcSEcCtD
Pentamidine—Neutropenia—Capecitabine—esophageal cancer	0.000551	0.00266	CcSEcCtD
Pentamidine—Renal failure acute—Methotrexate—esophageal cancer	0.000549	0.00266	CcSEcCtD
Pentamidine—Hyperglycaemia—Capecitabine—esophageal cancer	0.000531	0.00257	CcSEcCtD
Pentamidine—Vision blurred—Cisplatin—esophageal cancer	0.000525	0.00254	CcSEcCtD
Pentamidine—Tremor—Cisplatin—esophageal cancer	0.000522	0.00252	CcSEcCtD
Pentamidine—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000521	0.00252	CcSEcCtD
Pentamidine—Lethargy—Methotrexate—esophageal cancer	0.000518	0.0025	CcSEcCtD
Pentamidine—Cerebrovascular accident—Methotrexate—esophageal cancer	0.000518	0.0025	CcSEcCtD
Pentamidine—Renal failure—Capecitabine—esophageal cancer	0.000516	0.00249	CcSEcCtD
Pentamidine—Neuropathy peripheral—Capecitabine—esophageal cancer	0.000515	0.00249	CcSEcCtD
Pentamidine—Anaemia—Cisplatin—esophageal cancer	0.000514	0.00249	CcSEcCtD
Pentamidine—Stomatitis—Capecitabine—esophageal cancer	0.000512	0.00247	CcSEcCtD
Pentamidine—Conjunctivitis—Capecitabine—esophageal cancer	0.00051	0.00247	CcSEcCtD
Pentamidine—Haematuria—Capecitabine—esophageal cancer	0.000501	0.00242	CcSEcCtD
Pentamidine—Leukopenia—Cisplatin—esophageal cancer	0.000498	0.00241	CcSEcCtD
Pentamidine—Convulsion—Cisplatin—esophageal cancer	0.000482	0.00233	CcSEcCtD
Pentamidine—Mood swings—Methotrexate—esophageal cancer	0.000481	0.00232	CcSEcCtD
Pentamidine—Bradycardia—Capecitabine—esophageal cancer	0.00048	0.00232	CcSEcCtD
Pentamidine—Myalgia—Cisplatin—esophageal cancer	0.000474	0.00229	CcSEcCtD
Pentamidine—Rhinitis—Capecitabine—esophageal cancer	0.000473	0.00228	CcSEcCtD
Pentamidine—Anxiety—Cisplatin—esophageal cancer	0.000472	0.00228	CcSEcCtD
Pentamidine—Hepatitis—Capecitabine—esophageal cancer	0.000471	0.00228	CcSEcCtD
Pentamidine—Hypoaesthesia—Capecitabine—esophageal cancer	0.000469	0.00227	CcSEcCtD
Pentamidine—Liver function test abnormal—Methotrexate—esophageal cancer	0.000468	0.00226	CcSEcCtD
Pentamidine—Discomfort—Cisplatin—esophageal cancer	0.000468	0.00226	CcSEcCtD
Pentamidine—Pharyngitis—Capecitabine—esophageal cancer	0.000468	0.00226	CcSEcCtD
Pentamidine—Oedema peripheral—Capecitabine—esophageal cancer	0.000464	0.00224	CcSEcCtD
Pentamidine—Anaphylactic shock—Cisplatin—esophageal cancer	0.000454	0.0022	CcSEcCtD
Pentamidine—Infection—Cisplatin—esophageal cancer	0.000451	0.00218	CcSEcCtD
Pentamidine—Erythema multiforme—Capecitabine—esophageal cancer	0.000446	0.00215	CcSEcCtD
Pentamidine—Thrombocytopenia—Cisplatin—esophageal cancer	0.000445	0.00215	CcSEcCtD
Pentamidine—Tachycardia—Cisplatin—esophageal cancer	0.000443	0.00214	CcSEcCtD
Pentamidine—Asthma—Methotrexate—esophageal cancer	0.000438	0.00212	CcSEcCtD
Pentamidine—Flushing—Capecitabine—esophageal cancer	0.000437	0.00211	CcSEcCtD
Pentamidine—Eosinophilia—Methotrexate—esophageal cancer	0.000434	0.0021	CcSEcCtD
Pentamidine—Anorexia—Cisplatin—esophageal cancer	0.000433	0.00209	CcSEcCtD
Pentamidine—Pancreatitis—Methotrexate—esophageal cancer	0.00043	0.00208	CcSEcCtD
Pentamidine—Hypotension—Cisplatin—esophageal cancer	0.000425	0.00205	CcSEcCtD
Pentamidine—Chills—Capecitabine—esophageal cancer	0.000423	0.00204	CcSEcCtD
Pentamidine—Arrhythmia—Capecitabine—esophageal cancer	0.000421	0.00204	CcSEcCtD
Pentamidine—Pancytopenia—Methotrexate—esophageal cancer	0.000416	0.00201	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000414	0.002	CcSEcCtD
Pentamidine—Erythema—Capecitabine—esophageal cancer	0.00041	0.00198	CcSEcCtD
Pentamidine—Neutropenia—Methotrexate—esophageal cancer	0.00041	0.00198	CcSEcCtD
Pentamidine—Paraesthesia—Cisplatin—esophageal cancer	0.000408	0.00197	CcSEcCtD
Pentamidine—Dyspnoea—Cisplatin—esophageal cancer	0.000405	0.00196	CcSEcCtD
Pentamidine—Dysgeusia—Capecitabine—esophageal cancer	0.000402	0.00194	CcSEcCtD
Pentamidine—Decreased appetite—Cisplatin—esophageal cancer	0.000395	0.00191	CcSEcCtD
Pentamidine—Drowsiness—Methotrexate—esophageal cancer	0.000391	0.00189	CcSEcCtD
Pentamidine—Pain—Cisplatin—esophageal cancer	0.000388	0.00188	CcSEcCtD
Pentamidine—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.000388	0.00187	CcSEcCtD
Pentamidine—Vision blurred—Capecitabine—esophageal cancer	0.000387	0.00187	CcSEcCtD
Pentamidine—Tremor—Capecitabine—esophageal cancer	0.000384	0.00186	CcSEcCtD
Pentamidine—Renal failure—Methotrexate—esophageal cancer	0.000384	0.00186	CcSEcCtD
Pentamidine—Stomatitis—Methotrexate—esophageal cancer	0.000381	0.00184	CcSEcCtD
Pentamidine—Conjunctivitis—Methotrexate—esophageal cancer	0.00038	0.00184	CcSEcCtD
Pentamidine—Anaemia—Capecitabine—esophageal cancer	0.000379	0.00183	CcSEcCtD
Pentamidine—Feeling abnormal—Cisplatin—esophageal cancer	0.000374	0.00181	CcSEcCtD
Pentamidine—Haematuria—Methotrexate—esophageal cancer	0.000373	0.0018	CcSEcCtD
Pentamidine—Vertigo—Capecitabine—esophageal cancer	0.000369	0.00178	CcSEcCtD
Pentamidine—Syncope—Capecitabine—esophageal cancer	0.000368	0.00178	CcSEcCtD
Pentamidine—Leukopenia—Capecitabine—esophageal cancer	0.000367	0.00178	CcSEcCtD
Pentamidine—Palpitations—Capecitabine—esophageal cancer	0.000363	0.00175	CcSEcCtD
Pentamidine—Loss of consciousness—Capecitabine—esophageal cancer	0.000361	0.00174	CcSEcCtD
Pentamidine—Body temperature increased—Cisplatin—esophageal cancer	0.000359	0.00174	CcSEcCtD
Pentamidine—Cough—Capecitabine—esophageal cancer	0.000358	0.00173	CcSEcCtD
Pentamidine—Hypertension—Capecitabine—esophageal cancer	0.000354	0.00171	CcSEcCtD
Pentamidine—Hepatitis—Methotrexate—esophageal cancer	0.000351	0.0017	CcSEcCtD
Pentamidine—Arthralgia—Capecitabine—esophageal cancer	0.000349	0.00169	CcSEcCtD
Pentamidine—Chest pain—Capecitabine—esophageal cancer	0.000349	0.00169	CcSEcCtD
Pentamidine—Myalgia—Capecitabine—esophageal cancer	0.000349	0.00169	CcSEcCtD
Pentamidine—Pharyngitis—Methotrexate—esophageal cancer	0.000348	0.00168	CcSEcCtD
Pentamidine—Anxiety—Capecitabine—esophageal cancer	0.000348	0.00168	CcSEcCtD
Pentamidine—Discomfort—Capecitabine—esophageal cancer	0.000345	0.00167	CcSEcCtD
Pentamidine—Dry mouth—Capecitabine—esophageal cancer	0.000342	0.00165	CcSEcCtD
Pentamidine—Confusional state—Capecitabine—esophageal cancer	0.000338	0.00163	CcSEcCtD
Pentamidine—Hypersensitivity—Cisplatin—esophageal cancer	0.000335	0.00162	CcSEcCtD
Pentamidine—Infection—Capecitabine—esophageal cancer	0.000333	0.00161	CcSEcCtD
Pentamidine—Erythema multiforme—Methotrexate—esophageal cancer	0.000332	0.0016	CcSEcCtD
Pentamidine—Shock—Capecitabine—esophageal cancer	0.000329	0.00159	CcSEcCtD
Pentamidine—Thrombocytopenia—Capecitabine—esophageal cancer	0.000328	0.00158	CcSEcCtD
Pentamidine—Tachycardia—Capecitabine—esophageal cancer	0.000327	0.00158	CcSEcCtD
Pentamidine—Asthenia—Cisplatin—esophageal cancer	0.000326	0.00158	CcSEcCtD
Pentamidine—Anorexia—Capecitabine—esophageal cancer	0.000319	0.00154	CcSEcCtD
Pentamidine—Chills—Methotrexate—esophageal cancer	0.000315	0.00152	CcSEcCtD
Pentamidine—Hypotension—Capecitabine—esophageal cancer	0.000313	0.00151	CcSEcCtD
Pentamidine—Diarrhoea—Cisplatin—esophageal cancer	0.000311	0.0015	CcSEcCtD
Pentamidine—Erythema—Methotrexate—esophageal cancer	0.000305	0.00148	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000305	0.00147	CcSEcCtD
Pentamidine—Insomnia—Capecitabine—esophageal cancer	0.000303	0.00146	CcSEcCtD
Pentamidine—Paraesthesia—Capecitabine—esophageal cancer	0.000301	0.00145	CcSEcCtD
Pentamidine—Dysgeusia—Methotrexate—esophageal cancer	0.000299	0.00145	CcSEcCtD
Pentamidine—Dyspnoea—Capecitabine—esophageal cancer	0.000299	0.00144	CcSEcCtD
Pentamidine—Dyspepsia—Capecitabine—esophageal cancer	0.000295	0.00142	CcSEcCtD
Pentamidine—Decreased appetite—Capecitabine—esophageal cancer	0.000291	0.00141	CcSEcCtD
Pentamidine—Vomiting—Cisplatin—esophageal cancer	0.000289	0.0014	CcSEcCtD
Pentamidine—Fatigue—Capecitabine—esophageal cancer	0.000289	0.0014	CcSEcCtD
Pentamidine—Vision blurred—Methotrexate—esophageal cancer	0.000288	0.00139	CcSEcCtD
Pentamidine—Rash—Cisplatin—esophageal cancer	0.000286	0.00138	CcSEcCtD
Pentamidine—Pain—Capecitabine—esophageal cancer	0.000286	0.00138	CcSEcCtD
Pentamidine—Constipation—Capecitabine—esophageal cancer	0.000286	0.00138	CcSEcCtD
Pentamidine—Dermatitis—Cisplatin—esophageal cancer	0.000286	0.00138	CcSEcCtD
Pentamidine—Anaemia—Methotrexate—esophageal cancer	0.000282	0.00136	CcSEcCtD
Pentamidine—Feeling abnormal—Capecitabine—esophageal cancer	0.000276	0.00133	CcSEcCtD
Pentamidine—Vertigo—Methotrexate—esophageal cancer	0.000274	0.00133	CcSEcCtD
Pentamidine—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000274	0.00132	CcSEcCtD
Pentamidine—Leukopenia—Methotrexate—esophageal cancer	0.000273	0.00132	CcSEcCtD
Pentamidine—Nausea—Cisplatin—esophageal cancer	0.00027	0.0013	CcSEcCtD
Pentamidine—Cough—Methotrexate—esophageal cancer	0.000267	0.00129	CcSEcCtD
Pentamidine—Urticaria—Capecitabine—esophageal cancer	0.000266	0.00129	CcSEcCtD
Pentamidine—Body temperature increased—Capecitabine—esophageal cancer	0.000265	0.00128	CcSEcCtD
Pentamidine—Abdominal pain—Capecitabine—esophageal cancer	0.000265	0.00128	CcSEcCtD
Pentamidine—Convulsion—Methotrexate—esophageal cancer	0.000265	0.00128	CcSEcCtD
Pentamidine—Chest pain—Methotrexate—esophageal cancer	0.00026	0.00126	CcSEcCtD
Pentamidine—Myalgia—Methotrexate—esophageal cancer	0.00026	0.00126	CcSEcCtD
Pentamidine—Arthralgia—Methotrexate—esophageal cancer	0.00026	0.00126	CcSEcCtD
Pentamidine—Discomfort—Methotrexate—esophageal cancer	0.000257	0.00124	CcSEcCtD
Pentamidine—Confusional state—Methotrexate—esophageal cancer	0.000251	0.00121	CcSEcCtD
Pentamidine—Anaphylactic shock—Methotrexate—esophageal cancer	0.000249	0.0012	CcSEcCtD
Pentamidine—Infection—Methotrexate—esophageal cancer	0.000248	0.0012	CcSEcCtD
Pentamidine—Hypersensitivity—Capecitabine—esophageal cancer	0.000247	0.00119	CcSEcCtD
Pentamidine—Thrombocytopenia—Methotrexate—esophageal cancer	0.000244	0.00118	CcSEcCtD
Pentamidine—Asthenia—Capecitabine—esophageal cancer	0.00024	0.00116	CcSEcCtD
Pentamidine—Anorexia—Methotrexate—esophageal cancer	0.000238	0.00115	CcSEcCtD
Pentamidine—Pruritus—Capecitabine—esophageal cancer	0.000237	0.00115	CcSEcCtD
Pentamidine—Hypotension—Methotrexate—esophageal cancer	0.000233	0.00113	CcSEcCtD
Pentamidine—Diarrhoea—Capecitabine—esophageal cancer	0.000229	0.00111	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000227	0.0011	CcSEcCtD
Pentamidine—Insomnia—Methotrexate—esophageal cancer	0.000225	0.00109	CcSEcCtD
Pentamidine—Paraesthesia—Methotrexate—esophageal cancer	0.000224	0.00108	CcSEcCtD
Pentamidine—Dyspnoea—Methotrexate—esophageal cancer	0.000222	0.00107	CcSEcCtD
Pentamidine—Somnolence—Methotrexate—esophageal cancer	0.000222	0.00107	CcSEcCtD
Pentamidine—Dizziness—Capecitabine—esophageal cancer	0.000221	0.00107	CcSEcCtD
Pentamidine—Dyspepsia—Methotrexate—esophageal cancer	0.000219	0.00106	CcSEcCtD
Pentamidine—Decreased appetite—Methotrexate—esophageal cancer	0.000217	0.00105	CcSEcCtD
Pentamidine—Fatigue—Methotrexate—esophageal cancer	0.000215	0.00104	CcSEcCtD
Pentamidine—Pain—Methotrexate—esophageal cancer	0.000213	0.00103	CcSEcCtD
Pentamidine—Vomiting—Capecitabine—esophageal cancer	0.000213	0.00103	CcSEcCtD
Pentamidine—Rash—Capecitabine—esophageal cancer	0.000211	0.00102	CcSEcCtD
Pentamidine—Dermatitis—Capecitabine—esophageal cancer	0.000211	0.00102	CcSEcCtD
Pentamidine—Headache—Capecitabine—esophageal cancer	0.00021	0.00101	CcSEcCtD
Pentamidine—Feeling abnormal—Methotrexate—esophageal cancer	0.000205	0.000993	CcSEcCtD
Pentamidine—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000204	0.000985	CcSEcCtD
Pentamidine—Nausea—Capecitabine—esophageal cancer	0.000199	0.000961	CcSEcCtD
Pentamidine—Urticaria—Methotrexate—esophageal cancer	0.000198	0.000957	CcSEcCtD
Pentamidine—Abdominal pain—Methotrexate—esophageal cancer	0.000197	0.000953	CcSEcCtD
Pentamidine—Body temperature increased—Methotrexate—esophageal cancer	0.000197	0.000953	CcSEcCtD
Pentamidine—Hypersensitivity—Methotrexate—esophageal cancer	0.000184	0.000888	CcSEcCtD
Pentamidine—Asthenia—Methotrexate—esophageal cancer	0.000179	0.000865	CcSEcCtD
Pentamidine—Pruritus—Methotrexate—esophageal cancer	0.000176	0.000853	CcSEcCtD
Pentamidine—Diarrhoea—Methotrexate—esophageal cancer	0.000171	0.000824	CcSEcCtD
Pentamidine—Dizziness—Methotrexate—esophageal cancer	0.000165	0.000797	CcSEcCtD
Pentamidine—Vomiting—Methotrexate—esophageal cancer	0.000159	0.000766	CcSEcCtD
Pentamidine—Rash—Methotrexate—esophageal cancer	0.000157	0.00076	CcSEcCtD
Pentamidine—Dermatitis—Methotrexate—esophageal cancer	0.000157	0.000759	CcSEcCtD
Pentamidine—Headache—Methotrexate—esophageal cancer	0.000156	0.000755	CcSEcCtD
Pentamidine—Nausea—Methotrexate—esophageal cancer	0.000148	0.000716	CcSEcCtD
Pentamidine—S100B—Signaling Pathways—CREBBP—esophageal cancer	3.64e-05	0.000131	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—ABCB1—esophageal cancer	3.62e-05	0.000131	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	3.59e-05	0.000129	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—SLC10A2—esophageal cancer	3.58e-05	0.000129	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—CA1—esophageal cancer	3.58e-05	0.000129	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—ADH1B—esophageal cancer	3.45e-05	0.000125	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PLCE1—esophageal cancer	3.41e-05	0.000123	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—ADH7—esophageal cancer	3.41e-05	0.000123	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	3.37e-05	0.000122	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—TYMP—esophageal cancer	3.3e-05	0.000119	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—SLC10A2—esophageal cancer	3.29e-05	0.000119	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—CA1—esophageal cancer	3.29e-05	0.000119	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—BLVRB—esophageal cancer	3.28e-05	0.000118	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—SLC52A3—esophageal cancer	3.28e-05	0.000118	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—CA2—esophageal cancer	3.28e-05	0.000118	CbGpPWpGaD
Pentamidine—S100B—Immune System—EGFR—esophageal cancer	3.27e-05	0.000118	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—ADH1B—esophageal cancer	3.26e-05	0.000118	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—NOS3—esophageal cancer	3.26e-05	0.000118	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—CYP26A1—esophageal cancer	3.21e-05	0.000116	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	3.2e-05	0.000116	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—ALOX15—esophageal cancer	3.13e-05	0.000113	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—TYMP—esophageal cancer	3.12e-05	0.000113	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—ERBB2—esophageal cancer	3.05e-05	0.00011	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—ADH7—esophageal cancer	3.05e-05	0.00011	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PLCE1—esophageal cancer	3.05e-05	0.00011	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—CYP26A1—esophageal cancer	3.03e-05	0.00011	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—CA2—esophageal cancer	3.01e-05	0.000109	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	3.01e-05	0.000109	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—ADH1B—esophageal cancer	2.99e-05	0.000108	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—GSTO1—esophageal cancer	2.99e-05	0.000108	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—TPI1—esophageal cancer	2.99e-05	0.000108	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—ALOX15—esophageal cancer	2.96e-05	0.000107	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	2.93e-05	0.000106	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—ALDOB—esophageal cancer	2.86e-05	0.000103	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—TYMP—esophageal cancer	2.86e-05	0.000103	CbGpPWpGaD
Pentamidine—S100B—Immune System—PIK3CA—esophageal cancer	2.83e-05	0.000102	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—GSTO1—esophageal cancer	2.82e-05	0.000102	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—TPI1—esophageal cancer	2.82e-05	0.000102	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PLCE1—esophageal cancer	2.8e-05	0.000101	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—ADH7—esophageal cancer	2.8e-05	0.000101	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—CA1—esophageal cancer	2.79e-05	0.000101	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—SLC10A2—esophageal cancer	2.79e-05	0.000101	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—CYP26A1—esophageal cancer	2.78e-05	0.0001	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—GAPDH—esophageal cancer	2.76e-05	9.95e-05	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.73e-05	9.87e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—CRABP1—esophageal cancer	2.73e-05	9.86e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—ALOX15—esophageal cancer	2.71e-05	9.78e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—ALDOB—esophageal cancer	2.7e-05	9.76e-05	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—CCND1—esophageal cancer	2.69e-05	9.72e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—ADH1B—esophageal cancer	2.67e-05	9.64e-05	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—CDKN1A—esophageal cancer	2.6e-05	9.4e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—GAPDH—esophageal cancer	2.6e-05	9.4e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—GNG7—esophageal cancer	2.6e-05	9.37e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—GSTO1—esophageal cancer	2.59e-05	9.33e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—TPI1—esophageal cancer	2.59e-05	9.33e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—CRABP1—esophageal cancer	2.58e-05	9.31e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—CA2—esophageal cancer	2.55e-05	9.21e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—TYMP—esophageal cancer	2.55e-05	9.21e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—BLVRB—esophageal cancer	2.53e-05	9.14e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—SLC52A3—esophageal cancer	2.53e-05	9.14e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	2.49e-05	9.01e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—CYP26A1—esophageal cancer	2.48e-05	8.96e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—ALDOB—esophageal cancer	2.48e-05	8.95e-05	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—EP300—esophageal cancer	2.48e-05	8.94e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—ADH1B—esophageal cancer	2.46e-05	8.87e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—GNG7—esophageal cancer	2.45e-05	8.86e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—ALDH2—esophageal cancer	2.43e-05	8.78e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—ALOX15—esophageal cancer	2.42e-05	8.73e-05	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—CREBBP—esophageal cancer	2.42e-05	8.72e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—GAPDH—esophageal cancer	2.39e-05	8.61e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—ADH7—esophageal cancer	2.37e-05	8.57e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PLCE1—esophageal cancer	2.37e-05	8.57e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—CRABP1—esophageal cancer	2.37e-05	8.54e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—TYMP—esophageal cancer	2.35e-05	8.47e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	2.35e-05	8.47e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—GSTT1—esophageal cancer	2.31e-05	8.36e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—GSTO1—esophageal cancer	2.31e-05	8.33e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—TPI1—esophageal cancer	2.31e-05	8.33e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—ALDH2—esophageal cancer	2.3e-05	8.3e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—CYP2A6—esophageal cancer	2.29e-05	8.26e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—CYP26A1—esophageal cancer	2.28e-05	8.24e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—GNG7—esophageal cancer	2.25e-05	8.12e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—ALOX15—esophageal cancer	2.23e-05	8.03e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—ALDOB—esophageal cancer	2.21e-05	7.99e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—GSTT1—esophageal cancer	2.19e-05	7.89e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PTGS1—esophageal cancer	2.17e-05	7.83e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—ENO1—esophageal cancer	2.17e-05	7.83e-05	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—NOS3—esophageal cancer	2.16e-05	7.81e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—CYP2A6—esophageal cancer	2.16e-05	7.8e-05	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—MYC—esophageal cancer	2.16e-05	7.79e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CA1—esophageal cancer	2.15e-05	7.77e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—SLC10A2—esophageal cancer	2.15e-05	7.77e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	2.15e-05	7.77e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PSME2—esophageal cancer	2.14e-05	7.72e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PSME1—esophageal cancer	2.14e-05	7.72e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—GAPDH—esophageal cancer	2.13e-05	7.69e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—GSTO1—esophageal cancer	2.12e-05	7.66e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—TPI1—esophageal cancer	2.12e-05	7.66e-05	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—EGFR—esophageal cancer	2.11e-05	7.62e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—CRABP1—esophageal cancer	2.11e-05	7.62e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—ALDH2—esophageal cancer	2.11e-05	7.61e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—ADH1B—esophageal cancer	2.08e-05	7.51e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—ENO1—esophageal cancer	2.05e-05	7.4e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PTGS1—esophageal cancer	2.05e-05	7.4e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—ALDOB—esophageal cancer	2.04e-05	7.35e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PSME1—esophageal cancer	2.02e-05	7.29e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PSME2—esophageal cancer	2.02e-05	7.29e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—GNG7—esophageal cancer	2.01e-05	7.25e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—GSTT1—esophageal cancer	2.01e-05	7.24e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—TYMP—esophageal cancer	1.99e-05	7.18e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—CYP2A6—esophageal cancer	1.98e-05	7.15e-05	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—PTGS2—esophageal cancer	1.98e-05	7.14e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.97e-05	7.13e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CA2—esophageal cancer	1.97e-05	7.11e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—GAPDH—esophageal cancer	1.96e-05	7.07e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—CRABP1—esophageal cancer	1.94e-05	7.01e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—CYP26A1—esophageal cancer	1.93e-05	6.98e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—ALOX15—esophageal cancer	1.89e-05	6.8e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—ALDH2—esophageal cancer	1.88e-05	6.79e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—ENO1—esophageal cancer	1.88e-05	6.78e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PTGS1—esophageal cancer	1.88e-05	6.78e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PSME2—esophageal cancer	1.85e-05	6.68e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PSME1—esophageal cancer	1.85e-05	6.68e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—GNG7—esophageal cancer	1.85e-05	6.67e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—CYP1B1—esophageal cancer	1.84e-05	6.66e-05	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—PIK3CA—esophageal cancer	1.83e-05	6.62e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PLCE1—esophageal cancer	1.83e-05	6.61e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—ADH7—esophageal cancer	1.83e-05	6.61e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—TPI1—esophageal cancer	1.8e-05	6.49e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—GSTO1—esophageal cancer	1.8e-05	6.49e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—GSTT1—esophageal cancer	1.79e-05	6.46e-05	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—TP53—esophageal cancer	1.77e-05	6.4e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—CYP2A6—esophageal cancer	1.77e-05	6.39e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.76e-05	6.37e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.76e-05	6.36e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—CYP1B1—esophageal cancer	1.74e-05	6.29e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—CYP19A1—esophageal cancer	1.73e-05	6.26e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—ALDH2—esophageal cancer	1.73e-05	6.25e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—ALDOB—esophageal cancer	1.72e-05	6.22e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PTGS1—esophageal cancer	1.68e-05	6.05e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—ENO1—esophageal cancer	1.68e-05	6.05e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—GAPDH—esophageal cancer	1.66e-05	5.99e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PSME1—esophageal cancer	1.65e-05	5.96e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PSME2—esophageal cancer	1.65e-05	5.96e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—GSTT1—esophageal cancer	1.65e-05	5.94e-05	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—EP300—esophageal cancer	1.65e-05	5.94e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—CRABP1—esophageal cancer	1.64e-05	5.94e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—CYP19A1—esophageal cancer	1.64e-05	5.91e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—CYP2A6—esophageal cancer	1.63e-05	5.87e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.62e-05	5.84e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—ADH1B—esophageal cancer	1.61e-05	5.8e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—CYP1B1—esophageal cancer	1.6e-05	5.77e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—HMOX1—esophageal cancer	1.58e-05	5.71e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—GNG7—esophageal cancer	1.56e-05	5.65e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PTGS1—esophageal cancer	1.54e-05	5.57e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—ENO1—esophageal cancer	1.54e-05	5.57e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—TYMP—esophageal cancer	1.53e-05	5.54e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PSME2—esophageal cancer	1.52e-05	5.49e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PSME1—esophageal cancer	1.52e-05	5.49e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—ABCB1—esophageal cancer	1.52e-05	5.48e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—CYP19A1—esophageal cancer	1.5e-05	5.42e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—HMOX1—esophageal cancer	1.5e-05	5.4e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CYP26A1—esophageal cancer	1.49e-05	5.39e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.47e-05	5.29e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—ALDH2—esophageal cancer	1.47e-05	5.29e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—ALOX15—esophageal cancer	1.45e-05	5.25e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.44e-05	5.21e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—ABCB1—esophageal cancer	1.43e-05	5.18e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—CYP1B1—esophageal cancer	1.43e-05	5.15e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—GSTT1—esophageal cancer	1.39e-05	5.03e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—GSTO1—esophageal cancer	1.39e-05	5.01e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—TPI1—esophageal cancer	1.39e-05	5.01e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—CYP2A6—esophageal cancer	1.38e-05	4.98e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.37e-05	4.96e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—HMOX1—esophageal cancer	1.37e-05	4.95e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.34e-05	4.85e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—CYP19A1—esophageal cancer	1.34e-05	4.84e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—ALDOB—esophageal cancer	1.33e-05	4.8e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—ABCB1—esophageal cancer	1.32e-05	4.75e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—CYP1B1—esophageal cancer	1.31e-05	4.73e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—ENO1—esophageal cancer	1.31e-05	4.72e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PTGS1—esophageal cancer	1.31e-05	4.72e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PSME2—esophageal cancer	1.29e-05	4.65e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PSME1—esophageal cancer	1.29e-05	4.65e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—GAPDH—esophageal cancer	1.28e-05	4.62e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CRABP1—esophageal cancer	1.27e-05	4.58e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—CYP19A1—esophageal cancer	1.23e-05	4.45e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—HMOX1—esophageal cancer	1.22e-05	4.42e-05	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—PIK3CA—esophageal cancer	1.22e-05	4.39e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—GNG7—esophageal cancer	1.21e-05	4.36e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.2e-05	4.33e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—ABCB1—esophageal cancer	1.17e-05	4.24e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—ALDH2—esophageal cancer	1.13e-05	4.08e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—HMOX1—esophageal cancer	1.13e-05	4.06e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.12e-05	4.06e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—CYP1B1—esophageal cancer	1.11e-05	4.01e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.08e-05	3.92e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—ABCB1—esophageal cancer	1.08e-05	3.9e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—GSTT1—esophageal cancer	1.08e-05	3.88e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CYP2A6—esophageal cancer	1.06e-05	3.84e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—CYP19A1—esophageal cancer	1.04e-05	3.77e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—CREBBP—esophageal cancer	1.02e-05	3.66e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—ENO1—esophageal cancer	1.01e-05	3.64e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PTGS1—esophageal cancer	1.01e-05	3.64e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	9.95e-06	3.59e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PSME2—esophageal cancer	9.94e-06	3.59e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PSME1—esophageal cancer	9.94e-06	3.59e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—CREBBP—esophageal cancer	9.59e-06	3.46e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—HMOX1—esophageal cancer	9.53e-06	3.44e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	9.35e-06	3.38e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—ABCB1—esophageal cancer	9.15e-06	3.3e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—NOS3—esophageal cancer	9.09e-06	3.28e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	8.88e-06	3.2e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—CREBBP—esophageal cancer	8.79e-06	3.17e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—NOS3—esophageal cancer	8.59e-06	3.1e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CYP1B1—esophageal cancer	8.57e-06	3.1e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PTGS2—esophageal cancer	8.31e-06	3e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CYP19A1—esophageal cancer	8.06e-06	2.91e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—NOS3—esophageal cancer	7.87e-06	2.84e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PTGS2—esophageal cancer	7.85e-06	2.83e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—CREBBP—esophageal cancer	7.85e-06	2.83e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—HMOX1—esophageal cancer	7.36e-06	2.66e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—CREBBP—esophageal cancer	7.22e-06	2.61e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PTGS2—esophageal cancer	7.2e-06	2.6e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—ABCB1—esophageal cancer	7.06e-06	2.55e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—NOS3—esophageal cancer	7.03e-06	2.54e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	6.92e-06	2.5e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—EP300—esophageal cancer	6.91e-06	2.5e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—EP300—esophageal cancer	6.53e-06	2.36e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—NOS3—esophageal cancer	6.46e-06	2.33e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PTGS2—esophageal cancer	6.43e-06	2.32e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—CREBBP—esophageal cancer	6.11e-06	2.21e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—EP300—esophageal cancer	5.99e-06	2.16e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PTGS2—esophageal cancer	5.91e-06	2.13e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—NOS3—esophageal cancer	5.47e-06	1.98e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—EP300—esophageal cancer	5.34e-06	1.93e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PIK3CA—esophageal cancer	5.11e-06	1.85e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PTGS2—esophageal cancer	5.01e-06	1.81e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—EP300—esophageal cancer	4.92e-06	1.77e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PIK3CA—esophageal cancer	4.83e-06	1.74e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CREBBP—esophageal cancer	4.72e-06	1.7e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PIK3CA—esophageal cancer	4.43e-06	1.6e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—NOS3—esophageal cancer	4.23e-06	1.53e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—EP300—esophageal cancer	4.16e-06	1.5e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PIK3CA—esophageal cancer	3.95e-06	1.43e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PTGS2—esophageal cancer	3.86e-06	1.39e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PIK3CA—esophageal cancer	3.64e-06	1.31e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—EP300—esophageal cancer	3.21e-06	1.16e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PIK3CA—esophageal cancer	3.08e-06	1.11e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PIK3CA—esophageal cancer	2.38e-06	8.58e-06	CbGpPWpGaD
